AstraZeneca Pharma India Limited (ASTRAZEN.NS) NSE

Currency In INR

AstraZeneca Pharma India Limited

Address

Manyata Embassy Business Park

Bengaluru, 560045

India

Phone

91 80 6774 8000

Website

https://www.astrazeneca.in

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

940

First IPO Date

July 01, 2002

Key Executives

Name	Title	Pay	Year Born
Bhavana Agrawal	Whole-Time Director & Chief Financial Officer	23.24M	N/A
Srikanth S.	Site Lead, India Operations	0	N/A
Praveen Akkinepally	MD & Director	0	N/A
Sandhya Amanna	Director of Legal	0	N/A
Smita Saha	Vice President of Human Resources	0	1970
Tanya Sanish	Company Secretary and Compliance Officer	0	N/A
Ayush Kumar Agarwal	Business Unit Head of Biopharmaceutical Business Unit	0	N/A
Vinay Sharma	Business Unit Head - Rare Disease unit	0	N/A
Amarpreet Kaur Ahuja	Country HR Director	0	N/A

Description

AstraZeneca Pharma India Limited operates as a biopharmaceutical entity, engaged in the development, production, and global commercialization of pharmaceutical products, serving both the Indian domestic market and international clientele. The company offers an extensive range of medications, including treatments for cardiovascular conditions and diabetes, marketed under brands such as Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN. Its respiratory portfolio features products like Symbicort and FASENRA, while its oncology division provides various cancer therapies, including LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex. Furthermore, the firm extends its product line to encompass therapeutic solutions for renal, metabolic, and immunological disorders. Beyond its pharmaceutical offerings, AstraZeneca Pharma India Limited also provides clinical trial services. Established in 1979, the company is based in Bengaluru, India, and functions as a subsidiary of AstraZeneca Pharmaceuticals AB.